Unresectable Clear Cell Renal Cell Carcinoma
3 clinical trials · Condition
◉ Watch Unresectable Clear Cell Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial (NCT07576725) | Fred Hutchinson Cancer Center | 2026-09-01 |
| CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer (NCT05122546) | City of Hope Medical Center | 2021-11-01 |
| Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy (NCT04645680) | M.D. Anderson Cancer Center | 2020-06-24 |
Track Unresectable Clear Cell Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.